5/15/2013

Migraines too often are not recognized and treated in the U.S. even though clinicians have the tools to screen patients as well as effective medications, according to Richard Wenzel of the Diamond Headache Clinic and St. Joseph Hospital in Chicago. He told the APS' 32nd Annual Scientific Meeting that the disability associated with migraine episodes should not be underestimated. Only 18% of patients use triptans, the treatment of choice of the U.S. Headache Consortium, he said.

Related Summaries